Autologous hematopoietic stem cell transplantation in children with relapse or refractory Hodgkin disease

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 11, 2006, Pages 772-

  Galvão De Castro Jr , Cláudio ^a   Gregianin, Lauro José ^a   Brunetto, Algemir Lunardi ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; FOLLOW UP; HISTOLOGY; HODGKIN DISEASE; HUMAN; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; CHILD; DRUG RESISTANCE, NEOPLASM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; MALE; PROGNOSIS; RECURRENCE; SALVAGE THERAPY; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 33751221308     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000243655.18314.88     Document Type: Letter

References (4)

1. Stoneham S, Ashley S, Pinkerton CR, et al. United Kingdom Children's Cancer Study Group. Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease. J Pediatr Hematol Oncol. 2004;26:740-745.
2. Hudson MM, Donaldson SS. Treatment of pediatric Hodgkin's lymphoma. Semin Hematol. 1999;36:313-323.
3. Lieskovsky YE, Donaldson SS, Torres MA, et al. High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices. J Clin Oncol. 2004;22:4532-4540.
4. de Castro CG Jr, Gregianin LJ, Brunetto AL. Clinical and epidemiological analysis of bone marrow transplantation in a pediatric oncology unit. J Pediatr (Rio J). 2003;79:413-422.